Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim this study is the acquisition and management of a data base for the development of the glycaemic regulation algorithms. This database will integrate the measures of blood glucose and the glycaemia level of the Dexcom sensor on a regular time, the injections of insulin delivered by Debiotech JewelPUMP and the level of insulin in the blood. This database will also contain the bolus of insulin injected at meals and the content of meals, the reduction insulin level during physical activity and the quantification of this physical activity. A study will also be conducted to compare the pharmacokinetics of a bolus of insulin identical with the JewelPUMP either the usual pump of the patient.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| D-3 sensor | Experimental | patients will be equiped with 2 Dexcom sensors 3 days before hospitalization |
|
| D-1 sensor | Experimental | patients will be equiped with 2 Dexcom sensors one day before hospitalization |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dexcom7 | Device | patients will wear 2 Dexcom sensors 3 days before hospitalization. |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of data collected | The aim of the study is data collection of patient blood glucose and insulin in patients treated with continuous subcutaneous infusion insulin pump with a patchpump (JewelPUMPTM Debiotech) and equipped with two glucose sensors for the development of the control algorithm glucose. Blood sample are done every hour (achievement of glucose and insulin assays) ans every 15 minutes during 2 hours after meals. | Blood glucose and insuline will be collected during the hospital stay of patient (in average 25 hours) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Guillaume CHARPENTIER, MD | Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète | Study Chair |
| Bruno GUERCI, MD PHD | Central Hospital, Nancy, France | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chu Montpellier | Montpellier | Montpellier | 34295 | France | ||
| CHU Toulouse |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dexcom7 |
| Device |
patients will wear 2 Dexcom sensor one day before hospitalization |
|
| Toulouse |
| Toulouse |
| 31403 |
| France |
| CHU Jean Minjoz | Besançon | 25030 | France |
| CHU de Caen | Caen | 14000 | France |
| Centre Hospitalier Sud Francilien | Corbeil-Essonnes | 91106 | France |
| University Hospital Grenoble | Grenoble | 38043 | France |
| CHU de Nancy | Nancy | 54500 | France |
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided